Cargando…
抗肿瘤药物警戒研究进展
In 2019, Drug Administration Law of China was first time proposed that the country should establish pharmacovigilance system. In 2021, the first Pharmacovigilance Quality Management Standard of China was released. The proposal and implementation of pharmacovigilance were the initial stage in China,...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346154/ https://www.ncbi.nlm.nih.gov/pubmed/35899454 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.33 |
Ejemplares similares
-
浅析MIDD在抗肿瘤药物临床研究中的应用
Publicado: (2022) -
核酸干扰药物在抗肿瘤领域的机遇和挑战
Publicado: (2022) -
抗体偶联药物在肺癌中的研究进展与展望
Publicado: (2022) -
肺癌药物临床试验中研究护士的角色职能与作用
Publicado: (2022) -
肺癌脑膜转移癌诊疗的研究进展
Publicado: (2022)